Company news
Adalta Ltd. (ASX:1AD) news
Adalta Ltd. news releases on 6ix. Latest, Oct 15, 2018: Manufacturing Update
Press releases — page 4
Manufacturing Update
October 14, 2018
Change of Registry Address: Automic P/L - Sydney Office
September 28, 2018
Investor presentation and conference call
July 31, 2018
Appendix 4C - Quarter ended 30 June 2018
July 15, 2018
Completion of Capital Raise - $4.25m to advance AD-214
July 12, 2018
AdAlta secures key manufacturing agreements for AD-214
June 4, 2018
Appendix 4C - Quarter Ended 31 March 2018
April 22, 2018
AdAlta to advance improved lung fibrosis therapy, AD-214
April 17, 2018
AdAlta collaborator awarded NHMRC grant
December 6, 2017
AdAlta granted key Australian Patent
November 16, 2017
Commercial agreement with XL-protein
November 13, 2017
Conference Presentation
October 31, 2017
Results of multi-dose toxicology study
September 18, 2017
AdAlta awarded SIEF grant
July 23, 2017
Toxicology study and manufacturing update
July 17, 2017
Presentation of Eye Fobrosis Data at ARVO Meeting
May 8, 2017
AdAlta expands partnership with Alfred Hospital
March 20, 2017
AdAlta receives Orphan Designation for AD-114
January 18, 2017
Positive Pre-clinical Data
January 8, 2017
Commercialisation Agreement with Crossbeta Biosciences
November 7, 2016
Quarterly Review and Appendix 4C
October 26, 2016
Receipt of Innovation Connections Grant
September 13, 2016
Agreement with FujiFilm Diosynth Biotechnologies
September 12, 2016